The Hindu

Dr. Reddy's Lab third quarter net jumps to Rs.513 crore
The Hindu
The growth was led by the high value launch of Olanzapine 20 mg which alone accounted for revenue of $99 million, new products launched in the last 12 months and strong volume growth generated by key products such as lansoprazole, tacrolimus and ...
Dr Reddy's posts 88% jump in Q3 net profit to Rs 513 crZee News
Net soars 88% at Rs 512 croreHindu Business Line
Dr Reddy's profit rises 88% on schizophrenia drug salesLivemint
all 50 news articles »